Edition:
United States

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

1.90USD
17 Sep 2018
Change (% chg)

-- (--)
Prev Close
$1.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
33,404
52-wk High
$7.68
52-wk Low
$1.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.199
Mar '18 0.24 -0.212
FY 2017 Dec '17 0.00 -0.209
Sep '17 0.00 -0.429
Jun '17 0.00 -0.411
Mar '17 0.67 -0.468
FY 2016 Dec '16 0.68 -0.442
Sep '16 0.61 -0.617
Jun '16 0.61 -0.721
Mar '16 0.64 -0.698
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.20 0.60 0.00 0.60
Quarter Ending Dec-18 3 0.29 0.60 0.00 0.60
Year Ending Dec-18 4 0.58 1.40 0.20 1.00
Year Ending Dec-19 4 0.62 2.00 0.00 2.00
Earnings (per share)
Quarter Ending Sep-18 3 -0.22 -0.19 -0.25 -0.17
Quarter Ending Dec-18 3 -0.22 -0.15 -0.25 -0.21
Year Ending Dec-18 4 -0.85 -0.73 -0.91 -1.39
Year Ending Dec-19 4 -1.03 -0.70 -1.41 -1.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 103.50 32.14
P/E High - Last 5 Yrs. -- 275.43 47.40
P/E Low - Last 5 Yrs. -- 97.43 24.78
Beta 1.84 0.62 0.87
Price to Sales (TTM) 289.71 109.71 6.23
Price to Book (MRQ) -- 12.03 3.80
Price to Tangible Book (MRQ) 6.88 18.41 5.78
Price to Cash Flow (TTM) -- 59.58 22.50
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.55 -5.60
Payout Ratio(TTM) -- 5.86 46.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 174.85 8.41
Sales (TTM) vs TTM 1 Yr. Ago -87.88 91.86 6.69
Sales - 5 Yr. Growth Rate -29.18 24.26 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 51.63 272.94 25.39
EPS (TTM) vs TTM 1 Yr. Ago 45.91 -- --
EPS - 5 Yr. Growth Rate -- 23.39 7.57
Capital Spending - 5 Yr. Growth Rate -- 38.46 8.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.18
Current Ratio (MRQ) 1.82 5.48 2.95
LT Debt to Equity (MRQ) 0.00 14.97 11.33
Total Debt to Equity (MRQ) 73.18 18.40 14.17
Interest Coverage (TTM) -19.52 -204.17 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.80 54.77
Gross Margin - 5 Yr. Avg. -- 52.46 53.26
EBITD Margin (TTM) -12,673.42 -- --
EBITD - 5 Yr. Avg -936.57 -175.51 15.90
Operating Margin (TTM) -12,677.21 -608.67 3.68
Operating Margin - 5 Yr. Avg. -937.05 -189.07 11.01
Pre-Tax Margin (TTM) -13,035.87 -605.68 3.97
Pre-Tax Margin - 5 Yr. Avg. -940.85 -191.53 11.18
Net Profit Margin (TTM) -13,035.87 -601.23 0.71
Net Profit Margin - 5 Yr. Avg. -940.85 -189.32 7.52
Effective Tax Rate (TTM) -- 11.41 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.93 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 6,971 5,162,908 710,435,462
Net Income/Employee (TTM) -908,676 -6,026,407 81,903,466
Receivable Turnover (TTM) -- 5.43 5.02
Inventory Turnover (TTM) -- 2.04 3.62
Asset Turnover (TTM) 0.01 0.37 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -131.64 0.74 9.68
Return on Assets - 5 Yr. Avg. -82.10 2.54 10.88
Return on Investment (TTM) -221.44 1.52 12.66
Return on Investment - 5 Yr. Avg. -163.72 2.08 14.01
Return on Equity (TTM) -- 0.25 14.84
Return on Equity - 5 Yr. Avg. -694.48 -1.25 15.40
  1 Year 3 Year 5 Year
Sales % -73.62 -51.14 -29.18
EPS (TTM) % 40.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sunesis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.98%
# of Holders: 60
Total Shares Held: 23,481,144
3 Mo. Net Change: -2,123,936
# New Positions: 6
# Closed Positions: 10
# Increased Positions: 16
# Reduced Positions: 22
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.